Dexcom led a $75m Series D round in ŌURA.

Dexcom, a glucose biosensing company, led a $75m Series D round in ŌURA, a health technology company. “Dexcom offers the most accurate glucose biosensing systems on the market that help reveal the impact of daily lifestyle choices on glucose levels and enable our users to make informed decisions about their health and overall well-being. Partnering with ŌURA gives us the opportunity to redefine the category again, integrating data from Dexcom glucose biosensors with the continuous insights and metrics measured by Oura Ring. This powerful combination will attract new shared customers who want to better understand the link between activity, sleep, nutrition and their glucose," Matt Dolan, Dexcom Executive Vice President.